The Danish drugmaker, which is grappling with a share decline and competition from Eli Lilly, unveiled planned trials of an ...

Since the FDA said shortages of Wegovy and Zepbound are over, compounding pharmacies are supposed to stop making copies of the drugs. But some of those business are trying to find ways to continue.

Despite the jump in the number of teens being prescribed Wegovy, it still represents only a small fraction of kids who are living with obesity. Approximately one in 5 children and teens in the U.S.

Metsera is advancing promising obesity treatments with amylin and GLP-1 analogs, eyeing competitive efficacy and buyout ...

Early-stage study results suggest that a single shot of the company’s therapy, which works differently than GLP-1 medicines, ...

Fifteen Connecticut companies made the 2025 Fortune 500 list of the largest U.S. corporations, which was announced Monday-- a sign of stability in the state's corporate sector. Bloomfield- ...

Excess body weight can raise the risk of certain cancers, leading researchers to wonder whether blockbuster drugs like Wegovy, Ozempic ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

Some people see results in the first weeks of use Factors like metabolism and lifestyle habits can affect how they work Following a healthy diet and exercise can speed up results Some people see ...

Oh-oh-oh Ozempic, you know it's not the only weight loss injectable that's got people talking these days. Roughly three years ago we were still figuring out why exactly a large chunk of the Real ...

Donation Options Search Search Search Boxes of the weight-loss medications Wegovy and Zepbound. JoNel Aleccia ... data from 43 U.S. health systems to compare two groups: people with obesity ...

Over the past few years, demand for blockbuster medications like Ozempic, Wegovy and Zepbound skyrocketed. These drugs are typically prescribed to address a range of health issues, including ...